临床药物治疗杂志2024,Vol.22Issue(1) :85-87.DOI:10.3969/j.issn.1672-3384.2024.01.018

临床药师参与中枢神经系统毛霉菌感染治疗的实践及思考

Practice and experience of clinical pharmacists participating in the treatment of mucormycosis infection in central nervous system

庄伟 齐晓涟 高冉 张婧 杨毅恒 褚燕琦 董宪喆 张兰
临床药物治疗杂志2024,Vol.22Issue(1) :85-87.DOI:10.3969/j.issn.1672-3384.2024.01.018

临床药师参与中枢神经系统毛霉菌感染治疗的实践及思考

Practice and experience of clinical pharmacists participating in the treatment of mucormycosis infection in central nervous system

庄伟 1齐晓涟 1高冉 2张婧 2杨毅恒 3褚燕琦 1董宪喆 1张兰1
扫码查看

作者信息

  • 1. 首都医科大学宣武医院 药学部,北京 100053
  • 2. 首都医科大学宣武医院 神经内科,北京 100053
  • 3. 北京大学第三医院 药剂科,北京 100191
  • 折叠

摘要

中枢神经系统毛霉菌感染是一种病情凶险的颅内感染性疾病,病死率达到50%以上.本文介绍了2例中枢神经系统毛霉菌感染危重病例,并从全身治疗药物的选择、局部治疗用药的选择及两性霉素B的用法用量、治疗疗程与序贯治疗、输注过程中的监护、发生不良反应后的对策等方面进行总结与分析,以期为临床用药提供参考.

Abstract

Mucormycosis infection of the central nervous system is a dangerous intracranial infectious disease with a mor-tality rate of over 50%.In this paper,two cases of severe Mucormycosis infection in the central nervous system were intro-duced.The selection of systemic and local drugs,the usage and dosage of amphotericin B,the course of treatment and sequen-tial treatment,the monitoring and the countermeasures after adverse reactions caused by the application of amphotericin B were summarized and analyzed to a provide reference for clinicians and pharmacists.

关键词

毛霉菌感染/两性霉素B/临床药师

Key words

mucormycosis infection/amphotericin B/clinical pharmacist

引用本文复制引用

出版年

2024
临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
参考文献量11
段落导航相关论文